Reaction Details Report a problem with these data
Target
Free fatty acid receptor 1
Ligand
BDBM300855
Substrate
n/a
Meas. Tech.
GPR40 Calcium Flux Assay
EC50
890±n/a nM
Citation
 Huang, H; Kuo, G; Player, MR; Yang, S; Zhang, Y Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes US Patent  US10131648 Publication Date 11/20/2018 
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
  
Inhibitor
Name:
BDBM300855
Synonyms:
3-(4-(((3-(2- Methylphenyl)benzo[b]thiophen- 5-yl)oxy)methyl)phenyl) propanoic acid | US10131648, Compound 53 | US10195178, Compound 53 | US9790198, Compound 53
Type:
Small organic molecule
Emp. Form.:
C25H22O3S
Mol. Mass.:
402.505
SMILES:
Cc1ccccc1-c1csc2ccc(OCc3ccc(CCC(O)=O)cc3)cc12
Structure:
Search PDB for entries with ligand similarity: